Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03854916 · ClinicalTrials.gov registry record · NA
Caminamos: A Smartphone App for Latinas to Connect With Walking Partners
A NA study of Physical Activity, sponsored by Klein Buendel.
- Completed
- Registry status
- NA
- Development phase
- 78
- Enrollment target
- 2
- Study locations
NCT03854916: Completed NA study of Physical Activity, sponsored by Klein Buendel.
NCT03854916 is a NA study of Physical Activity that has completed, run by Klein Buendel. The registered enrollment target is 78 participants, below the 358-participant average among 131 other Physical Activity trials with a reported enrollment target (78% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03854916, a NA study of Physical Activity, has completed, sponsored by Klein Buendel.
- COMPLETED
- Registry status
- NA
- Development phase
- 78 participants
- Enrollment target
- 2
- Study locations
Study Summary
Despite numerous interventions designed to increase physical activity, few are specifically tailored to Latinas, a population where higher rates of obesity, diabetes, and other chronic diseases are present. This proposed smartphone app, ¡Caminemos Juntas!, will use location-based services to connect Latinas with one another in order to improve walking habits by increasing social support and decreasing perceived barriers, both of which are known to play a role in physical activity behaviors. Through a randomized comparative-effectiveness trial, this Phase II project will test the effectiveness of a smartphone application for improving physical activity among Latinas when providing them with real-time opportunities to connect socially with the goal of walking.
Primary Outcome
The Community Healthy Activities Model Program for Seniors (CHAMPS) is a 41-item PA questionnaire that measures self-reported minutes-per-week of PA calculated as total weekly caloric expenditure for all PA. It was developed for underactive populations and validated among older adults. However, CHAMPS has been used with younger and racially/ethnically diverse populations; it is sensitive to change specifically in Latino and other populations including ones younger than senior age. The CHAMPS ask
Conditions Studied
Interventions
- OTHER Caminemos Juntas App
- OTHER World Walking App
Study Locations (2)
California
- Stanford University - Stanford
Colorado
- Klein Buendel, Inc. - Golden
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2019-02-28 |
| Est. Completion | 2022-04-30 |
| Phase | NA |
What the finished NCT03854916 record still lists
NCT03854916 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 78 participants, a relatively small participant target, below the 358-participant average among 131 other Physical Activity trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Physical Activity appearing as the primary indexed condition, and to 2 interventions - of which Caminemos Juntas App is the first listed.
NCT03854916 reports a single indexed study location in California, Colorado.
Frequently Asked Questions
What is clinical trial NCT03854916 about?
NCT03854916 is a clinical study titled "Caminamos: A Smartphone App for Latinas to Connect With Walking Partners". Despite numerous interventions designed to increase physical activity, few are specifically tailored to Latinas, a population where higher rates of obesity, diabetes, and other chronic diseases are present. This proposed smartphone app, ¡Caminemos Juntas!, will use location-based services to connect...
What is the current status of trial NCT03854916?
This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2019-02-28. Estimated completion is 2022-04-30.
What conditions does trial NCT03854916 study?
This clinical trial studies the following conditions: Physical Activity.
What interventions are being tested in trial NCT03854916?
The interventions under investigation include: Caminemos Juntas App (OTHER), World Walking App (OTHER).
Who is sponsoring clinical trial NCT03854916?
This trial is sponsored by Klein Buendel, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03854916 being conducted?
This trial has 2 study locations across California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Physical Activity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03854916's enrollment target sits among peer trials
78 75th of 131 higher than 57 of 131 other Physical Activity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Physical Activity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Heterogeneity of Vascular Adaptations to Exercise With Aging in Women and Men
RECRUITING · NA
-
Goal Setting to Promote Physical Activity Adherence in Midlife Adults
RECRUITING · NA
-
Va Meh Du: A Sports-based Mental Health Promotion Intervention for Karenni Refugees
RECRUITING · NA
-
Teen Mom Study Feasibility Trial
RECRUITING · NA
-
The Fit With Us Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02397668 · 78 participants · NA
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
- NCT03321656 · 78 participants · Phase 2
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
- NCT03687814 · 78 participants · NA
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
- NCT04018872 · 78 participants · Phase 2
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI